Don’t miss the latest developments in business and finance.

Reliance Nippon Life ends at 12% premium against issue price

The stock listed at Rs 296, a 17% premium against its issue price of Rs 252 on the NSE. It was listed at Rs 294 on the BSE.

Reliance Nippon Life Insurance
Reliance Nippon Life Insurance (Photo: Wikimedia Commons)
SI Reporter Mumbai
Last Updated : Nov 06 2017 | 4:28 PM IST
Reliance Nippon Life Asset Management (RNLAM) made a strong debut on the bourses by listing at a 17% premium against its issue price of Rs 252 on the National Stock Exchange (NSE). The stock listed at Rs 294 on the BSE (the Bombay Stock Exchange).

The stock ended at Rs 284 on the BSE and NSE after hitting a low of Rs 278 post its listing. A combined 16.03 million shares changed hands on the counter on the BSE and NSE so far.

The company's Rs 1,540 crore initial public offer (IPO) got a strong demand in all the three investor categories. The IPO was oversubscribed 81.54 times at the close of the bidding, with bids for 3,493 million shares, worth Rs 88,023 crore, data available with the stock exchanges showed.

The portion of company’s IPO reserved for non-institutional investors was subscribed 209 times while the portion reserved for qualified institutional buyers (QIBs) was subscribed 118 times and the retail individual investors (RIIs) by 5.65 times, data shows.

RNLAM is the first mutual fund listing on Indian stock exchanges, had fixed the price band at Rs 247 -252 per share. This was also the first IPO from the Reliance group after Reliance Power in 2008. Other listed firms of the group include Reliance Capital, Reliance Home Finance, Reliance Communications, Reliance Naval and Engineering and Reliance Infra.

RNLAM intends to use the net proceedings for setting up new branches and relocating certain existing branches, upgrading the IT system, advertising, marketing and brand building activities, lending to its subsidiary (Reliance AIF) for investment as continuing interest in the new AIF schemes managed by Reliance AIF, investing towards its continuing interest in new mutual fund schemes managed by them, funding inorganic growth and other strategic initiatives and general corporate purposes.

“We like RNLAM as it is the largest AMC with highly diversified product offerings and strong distribution reach. RNLAM’s AUM has grown at CAGR of 22% in FY13-17 and has delivered strong Revenue/EBITDA/PAT growth of 21%/ 28%/ 15% over the same period. Other key strengths of the company are leadership positioning in AMC business with strong credentials to drive growth, strong distribution reach, diversified product mix with strong investment track record, and strong ROE/ ROCEs of 22%/ 25%,” analyst at Motilal Oswal Securities said in a IPO note.

“Considering that RNLAM is the third largest AMC coupled with huge potential of MF industry to grow, strong return ratios, asset light business, higher dividend payout ratio and track record of superior investment performance, we are positive on this IPO and rate it as SUBSCRIBE,” the brokerage firm Angel Broking had said in IPO note.

Next Story